C-suite exits as Cargo and Elevation restructure

Two biotechs are shedding C-suite executives as they restructure and explore strategic options.

President and CEO Gina Chapman and CMO Ginna Laport are leaving Cargo Therapeutics Inc. (NASDAQ:CRGX). After discontinuing development of CD22 CAR T therapy firicabtagene autoleucel last month, the company announced it is suspending all pipeline activities, cutting its workforce 90%, and seeking strategic alternatives. CFO and COO Anup Radhakrishnan will serve as interim CEO to lead the company through a reverse merger or other business combination. ...